Next Article in Journal
Hybrid and Vaccine-Induced Immunity Against SARS-CoV-2 in a Cohort of Hospitalized Patients from the Metropolitan Aburrá Valley, Colombia
Previous Article in Journal
Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015–2025

by
Tatjana Vilibić-Čavlek
1,2,*,†,
Klara Barbić
3,†,
Vesna Višekruna Vučina
4,
Maja Bogdanić
1,2 and
Bernard Kaić
4
1
WHO National Measles/Rubella Laboratory, Department of Virology, Croatian Institute of Public Health, 10000 Zagreb, Croatia
2
School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
3
Statistic Concentrator, Harvard University, Cambridge, MA 02139, USA
4
Department of Communicable Disease Epidemiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Vaccines 2026, 14(5), 393; https://doi.org/10.3390/vaccines14050393
Submission received: 14 March 2026 / Revised: 22 April 2026 / Accepted: 23 April 2026 / Published: 27 April 2026
(This article belongs to the Special Issue Measles Virus Vaccination and Infection)

Abstract

Background/Objectives: Measles is a highly contagious infectious disease. Maintaining a high level of measles immunity in the population is essential due to the extremely high transmissibility of the measles virus (MV). We analyzed the MV seroprevalence in the Croatian population. Methods: A total of 1998 individuals tested consecutively for MV antibodies from 2015 to 2025 inclusive were included. MV IgG antibodies were detected using a commercial ELISA. Results: The overall seroprevalence rate was 75.1%, with significant yearly differences, ranging from 50.0 to 86.5%, and a declining trend since 2023. No differences were observed between sexes (males 71.6%, females 71.9%). The seroprevalence increased with age, from 60.9% in the 1–10 age group to 91.1% in the 61+ age group. Significant geographic differences were found, with higher seropositivity rates in coastal regions compared to continental regions (81.3 and 71.0%, respectively). Settlement type (urban, suburban/rural) was not associated with the MV seroprevalence. The results of the multivariable logistic regression analysis showed that year, age, and region were significantly associated with IgG seropositivity. Each additional calendar year was associated with lower odds of IgG positivity (OR = 0.82), while each additional year of age was associated with higher odds (OR = 1.04). Region was also a significant predictor (OR = 1.65), while settlement was not significantly associated with seropositivity after adjustment for other variables. Conclusions: Croatia has historically maintained high measles coverage, but lower uptake in some regions and age groups may be creating immunity gaps. The lower post-2022 seropositivity underscores significant immunity gaps, particularly among highly susceptible groups that were exposed to outbreaks and tested during that period.
Keywords: measles virus; seroprevalence; epidemiology; Croatia measles virus; seroprevalence; epidemiology; Croatia

Share and Cite

MDPI and ACS Style

Vilibić-Čavlek, T.; Barbić, K.; Vučina, V.V.; Bogdanić, M.; Kaić, B. Assessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015–2025. Vaccines 2026, 14, 393. https://doi.org/10.3390/vaccines14050393

AMA Style

Vilibić-Čavlek T, Barbić K, Vučina VV, Bogdanić M, Kaić B. Assessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015–2025. Vaccines. 2026; 14(5):393. https://doi.org/10.3390/vaccines14050393

Chicago/Turabian Style

Vilibić-Čavlek, Tatjana, Klara Barbić, Vesna Višekruna Vučina, Maja Bogdanić, and Bernard Kaić. 2026. "Assessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015–2025" Vaccines 14, no. 5: 393. https://doi.org/10.3390/vaccines14050393

APA Style

Vilibić-Čavlek, T., Barbić, K., Vučina, V. V., Bogdanić, M., & Kaić, B. (2026). Assessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015–2025. Vaccines, 14(5), 393. https://doi.org/10.3390/vaccines14050393

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop